Mycobacteria Breadcrumb Home Glossary Mycobacteria Short description Mycobacteria are a bacterial genus, which includes the tuberculosis-causing Mycobacterium tuberculosis and the leprosy-causing Mycobacterium leprae. Detailed description Mycobacteria are commonly found in nature. They exist in soil and water and in all animal species. Some species cause disease in humans. More about “Mycobacteria” May 2024 RSC Med Chem Design, synthesis and antimycobacterial activity of imidazo[1,5-a]quinolines and their zinc-complexes Autoren Marner M et al. Feb 2024 J Proteome Res Discovery of Species-Specific Proteotypic Peptides To Establish a Spectral Library Platform for Identification of Nontuberculosis Mycobacteria from Mass Spectrometry-Based Proteomics Autoren Kotimoole CN et al. Dec 2023 Eur J Med Chem Whole cell hydride Meisenheimer complex biotransformation guided optimization of antimycobacterial benzothiazinones Autoren Joch M et al. Oct 2023 BMC Infect Dis Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon-a cross-sectional study Autoren Ndanga MED et al. 03 May 2024 Symposium Klinikum der Goethe Universität Frankfurt Theodor-Stern-Kai 7 I Hörsaal 23-3 60590 Frankfurt Germany public 2. Clinical Tuberculosis-Symposium Aug 2023 Elife Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasome Autoren Gessner S et al. Jun 2023 Clin Microbiol Infect Appeal from the European reference laboratory network for tuberculosis for improving the diagnosis of infections caused by non-tuberculous mycobacteria Autoren Tagliani E et al. Mar 2023 Antimicrob Agents Chemother Pharmacokinetics and Efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside Granulomas in the Guinea Pig Model Autoren Eckhardt E et al. Jun 2022 Front Pharmacol In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis Autoren Hoffmann AM et al. © Florian Kloß Jun 1 2023 Leibniz active agent of the year 2023 is a tuberculosis antibiotic candidate The drug candidate BTZ-043 has a novel mechanism of action and belongs to a new class of substances. Discovered at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI Pagination Previous page ‹‹ Seite 1 Current page 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Next page ››
May 2024 RSC Med Chem Design, synthesis and antimycobacterial activity of imidazo[1,5-a]quinolines and their zinc-complexes Autoren Marner M et al.
Feb 2024 J Proteome Res Discovery of Species-Specific Proteotypic Peptides To Establish a Spectral Library Platform for Identification of Nontuberculosis Mycobacteria from Mass Spectrometry-Based Proteomics Autoren Kotimoole CN et al.
Dec 2023 Eur J Med Chem Whole cell hydride Meisenheimer complex biotransformation guided optimization of antimycobacterial benzothiazinones Autoren Joch M et al.
Oct 2023 BMC Infect Dis Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon-a cross-sectional study Autoren Ndanga MED et al.
03 May 2024 Symposium Klinikum der Goethe Universität Frankfurt Theodor-Stern-Kai 7 I Hörsaal 23-3 60590 Frankfurt Germany public 2. Clinical Tuberculosis-Symposium
Aug 2023 Elife Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasome Autoren Gessner S et al.
Jun 2023 Clin Microbiol Infect Appeal from the European reference laboratory network for tuberculosis for improving the diagnosis of infections caused by non-tuberculous mycobacteria Autoren Tagliani E et al.
Mar 2023 Antimicrob Agents Chemother Pharmacokinetics and Efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside Granulomas in the Guinea Pig Model Autoren Eckhardt E et al.
Jun 2022 Front Pharmacol In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis Autoren Hoffmann AM et al.
